Literature DB >> 6592753

Pharmacological aspects of corticosteroid pulse therapy.

P J Pentikäinen.   

Abstract

Pulse corticosteroid therapy involves intravenous administration of "suprapharmacological" doses (0.5-2 g) of prednisolone or its equivalents. This dose is usually given on three consecutive days and possibly once a month thereafter. The pharmacological effects of the single pulse dose lasted for about two days. Whether these effects differ quantitatively or qualitatively from the effects of the smaller, conventional doses is unclear at present. The usual side-effects of glucocorticoid therapy may occur with pulse therapy but evidently less frequently than with conventional modes of steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6592753     DOI: 10.3109/03009748409103852

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  7 in total

1.  Efficacy of methylprednisolone in controlling complications after impacted lower third molar surgical extraction.

Authors:  J M Micó-Llorens; M Satorres-Nieto; J Gargallo-Albiol; J Arnabat-Domínguez; L Berini-Aytés; C Gay-Escoda
Journal:  Eur J Clin Pharmacol       Date:  2006-08-11       Impact factor: 2.953

2.  Nonspecific action of glucocorticosteroids after high-dose pulse therapy?

Authors:  R Hirschelmann; R Schade; W Bürger; H Bekemeier
Journal:  Agents Actions       Date:  1990-08

3.  Dexamethasone megadoses stabilize rat liver lysosomal membranes by non-genomic and genomic effects.

Authors:  B Hinz; R Hirschelmann
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

4.  Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy.

Authors:  Masaru Miura; Takuya Tamame; Takashi Naganuma; Shino Chinen; Megumi Matsuoka; Hirotaka Ohki
Journal:  Paediatr Child Health       Date:  2011-10       Impact factor: 2.253

5.  Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis.

Authors:  Hashem H Ghoraba; Wataru Matsumiya; Hassan Khojasteh; Amir Akhavanrezayat; Irmak Karaca; Christopher Or; Negin Yavari; Sherin Lajevardi; Jaclyn Hwang; Cigdem Yasar; Diana Do; Quan Dong Nguyen
Journal:  Clin Ophthalmol       Date:  2022-05-31

6.  Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.

Authors:  Masaru Miura; Kazuki Kohno; Hirotaka Ohki; Shigeki Yoshiba; Akinori Sugaya; Masaaki Satoh
Journal:  Eur J Pediatr       Date:  2008-01-04       Impact factor: 3.183

7.  Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease.

Authors:  Kai-Ling Yong; Chiaw Ling Chng; Hla Myint Htoon; Lee Hooi Lim; Lay Leng Seah
Journal:  Int J Endocrinol       Date:  2015-11-22       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.